Literature DB >> 21190089

Fetomaternal transfusion after amniocentesis and cordocentesis.

J Sikovanyecz1, E Horváth, N Pásztor, A Keresztúri, J Szabó, A Pál.   

Abstract

OBJECTIVE: To compare the extent of fetomaternal transfusion after amniocentesis and cordocentesis.
SETTING: Three-hundred and forty-five amniocentesis and 268 cordocentesis were performed for genetic indications. The extent of fetomaternal transfusion was calculated on the basis of the maternal serum alpha-fetoprotein level changes.
RESULTS: The mean fetomaternal transfusion was 6.3 and 62 μL in the amniocentesis and cordocentesis groups, respectively. Transplacental needle passage and longer procedural time were risk factors for fetomaternal transfusion. The frequency of transplacental passage was higher and the procedural time was longer in the cordocentesis group. The fetal loss rate was 1.17% after amniocentesis and 1.2% after cordocentesis, respectively.
CONCLUSIONS: Cordocentesis causes more injury to the extrafetal compartment, which results in a higher level of fetomaternal transfusion. However, though a nearly ten times higher fetomaternal transfusion was observed after cordocentesis, there was no essential difference in pregnancy outcome between the two groups.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21190089     DOI: 10.1007/s11845-010-0663-3

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  26 in total

1.  Cordocentesis at 16-24 weeks of gestation: experience of 1,320 cases.

Authors:  T Tongsong; C Wanapirak; C Kunavikatikul; S Sirirchotiyakul; W Piyamongkol; P Chanprapaph
Journal:  Prenat Diagn       Date:  2000-03       Impact factor: 3.050

2.  Alpha-fetoprotein elevation in maternal serum after percutaneous umbilical blood sampling (PUBS)

Authors:  M Buscaglia; L Ghisoni; P E Levi-Setti
Journal:  Prenat Diagn       Date:  1996-04       Impact factor: 3.050

3.  Safety of placental biopsy in the second and third trimesters.

Authors:  W Holzgreve; P Miny; S Basaran; W Fuhrmann; F K Beller
Journal:  N Engl J Med       Date:  1987-10-29       Impact factor: 91.245

4.  The pathogenesis and prevention of Rh immunization.

Authors:  A Zipursky; L G Israels
Journal:  Can Med Assoc J       Date:  1967-11-18       Impact factor: 8.262

5.  Surgical termination of pregnancy as a cause of rhesus sensitization.

Authors:  J Gellén; Z Kovács; F E Szontágh; D Boda
Journal:  Br Med J       Date:  1965-12-18

6.  Fetomaternal haemorrhage treated with intravascular transfusion: a late complication of amniocentesis?

Authors:  C F Kohlenberg; D A Ellwood
Journal:  Br J Obstet Gynaecol       Date:  1994-10

7.  Fetal loss rate associated with cordocentesis at midgestation.

Authors:  T Tongsong; C Wanapirak; C Kunavikatikul; S Sirirchotiyakul; W Piyamongkol; P Chanprapaph
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

8.  Risk factors predisposing to fetal loss following a second trimester amniocentesis.

Authors:  N E Papantoniou; G J Daskalakis; J G Tziotis; S J Kitmirides; S A Mesogitis; A J Antsaklis
Journal:  BJOG       Date:  2001-10       Impact factor: 6.531

9.  Prenatal genetic testing by amniocentesis appears to result in a lower risk of fetal loss than chorionic villus sampling in singleton pregnancies achieved by intracytoplasmic sperm injection.

Authors:  Efstratios Kolibianakis; Kaan Osmanagaoglu; Luc De Catte; Michel Camus; Maryse Bonduelle; Inge Liebaers; Andre Van Steirteghem; Paul Devroey
Journal:  Fertil Steril       Date:  2003-02       Impact factor: 7.329

10.  Blood volume changes in normal pregnancy.

Authors:  F Hytten
Journal:  Clin Haematol       Date:  1985-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.